These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38203184)

  • 1. Polycondensed Peptide-Based Polymers for Targeted Delivery of Anti-Angiogenic siRNA to Treat Endometriosis.
    Egorova A; Maretina M; Krylova I; Kiselev A
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis.
    Egorova A; Petrosyan M; Maretina M; Bazian E; Krylova I; Baranov V; Kiselev A
    Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-angiogenic treatment of endometriosis via anti-VEGFA siRNA delivery by means of peptide-based carrier in a rat subcutaneous model.
    Egorova A; Petrosyan M; Maretina M; Balashova N; Polyanskih L; Baranov V; Kiselev A
    Gene Ther; 2018 Dec; 25(8):548-555. PubMed ID: 30254304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGFA Gene Silencing in CXCR4-Expressing Cells via siRNA Delivery by Means of Targeted Peptide Carrier.
    Egorova AA; Maretina MA; Kiselev AV
    Methods Mol Biol; 2019; 1974():57-68. PubMed ID: 31098995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
    Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
    Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes.
    Egorova AA; Shtykalova SV; Maretina MA; Sokolov DI; Selkov SA; Baranov VS; Kiselev AV
    Pharmaceutics; 2019 Jun; 11(6):. PubMed ID: 31174285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models for anti-angiogenic therapy in endometriosis.
    Edwards AK; Nakamura DS; Virani S; Wessels JM; Tayade C
    J Reprod Immunol; 2013 Mar; 97(1):85-94. PubMed ID: 23432875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic properties of endometrial mesenchymal stromal cells in endothelial co-culture: an in vitro model of endometriosis.
    Canosa S; Moggio A; Brossa A; Pittatore G; Marchino GL; Leoncini S; Benedetto C; Revelli A; Bussolati B
    Mol Hum Reprod; 2017 Mar; 23(3):187-198. PubMed ID: 28158750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-Regulation of miR-93 Negatively Correlates with Overexpression of VEGFA and MMP3 in Endometriosis: A Cross-Sectional Study.
    Muharam R; Rahmala Febri R; Mutia K; Iffanolida PA; Maidarti M; Wiweko B; Hestiantoro A
    Int J Fertil Steril; 2023 Jan; 17(1):28-33. PubMed ID: 36617199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGA Controls VEGFA Secretion to Promote Angiogenesis by Activating the VEGFR2-FAK Signalling Pathway.
    Li H; Cai E; Cheng H; Ye X; Ma R; Zhu H; Chang X
    Front Endocrinol (Lausanne); 2022; 13():791860. PubMed ID: 35498401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proangiogenic properties of complement protein C1q can contribute to endometriosis.
    Agostinis C; Toffoli M; Zito G; Balduit A; Pegoraro S; Spazzapan M; Pascolo L; Romano F; Di Lorenzo G; Mangogna A; Santin A; Spedicati B; Valencic E; Girotto G; Ricci G; Kishore U; Bulla R
    Front Immunol; 2024; 15():1405597. PubMed ID: 38983846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis.
    Xu H; Zhang T; Man GC; May KE; Becker CM; Davis TN; Kung AL; Birsner AE; D'Amato RJ; Wong AW; Wang CC
    Angiogenesis; 2013 Jul; 16(3):541-51. PubMed ID: 23334337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis.
    Novella-Maestre E; Carda C; Noguera I; Ruiz-Saurí A; García-Velasco JA; Simón C; Pellicer A
    Hum Reprod; 2009 May; 24(5):1025-35. PubMed ID: 19189995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin attenuates expression of angiogenic and inflammatory genes in human endometriotic stromal cells.
    Yari S; Khoei HH; Saber M; Esfandiari F; Moini A; Shahhoseini M
    Exp Cell Res; 2021 Jul; 404(2):112659. PubMed ID: 34022204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal fluid reduces angiogenesis-related microRNA expression in cell cultures of endometrial and endometriotic tissues from women with endometriosis.
    Braza-Boïls A; Gilabert-Estellés J; Ramón LA; Gilabert J; Marí-Alexandre J; Chirivella M; España F; Estellés A
    PLoS One; 2013; 8(4):e62370. PubMed ID: 23620826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage migration inhibitory factor elicits an angiogenic phenotype in human ectopic endometrial cells and triggers the production of major angiogenic factors via CD44, CD74, and MAPK signaling pathways.
    Veillat V; Carli C; Metz CN; Al-Abed Y; Naccache PH; Akoum A
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E403-12. PubMed ID: 20829186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles.
    Vader P; Crielaard BJ; van Dommelen SM; van der Meel R; Storm G; Schiffelers RM
    J Control Release; 2012 Jun; 160(2):211-6. PubMed ID: 21983283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H
    J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ellagic acid metabolites urolithin A and B differentially affect growth, adhesion, motility, and invasion of endometriotic cells in vitro.
    Mc Cormack B; Maenhoudt N; Fincke V; Stejskalova A; Greve B; Kiesel L; Meresman GF; Vankelecom H; Götte M; Barañao RI
    Hum Reprod; 2021 May; 36(6):1501-1519. PubMed ID: 33748857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
    Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
    Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.